Financial results for Q1 ended March 31, 2026
GlaxoSmithKline (Pakistan) Limited (GLAXO) · View GLAXO share price and financials
Published
Announcement summary
This page records a Pakistan Stock Exchange corporate announcement from GlaxoSmithKline (Pakistan) Limited. Review the original filing for the complete terms and regulatory disclosure.
- Unconsolidated Sales
- 17028325
- Unconsolidated Pat
- 2610704
- Bonus
- 0
- Unconsolidated Quarter Eps
- 8.20
- Right Price
- 0